Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer.

Androgen deprivation therapy Cardiovascular risk Diabetes Hypogonadism Prostate cancer Testosterone

Journal

The world journal of men's health
ISSN: 2287-4208
Titre abrégé: World J Mens Health
Pays: Korea (South)
ID NLM: 101596899

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 06 2020
revised: 17 07 2020
accepted: 19 07 2020
pubmed: 20 8 2020
medline: 20 8 2020
entrez: 20 8 2020
Statut: ppublish

Résumé

Androgen deprivation therapy (ADT) is the gold standard treatment in patients with locally advanced or metastatic prostate cancer (PC). Emerging evidence has documented a

Identifiants

pubmed: 32814370
pii: 38.e47
doi: 10.5534/wjmh.200109
pmc: PMC8255402
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

429-443

Informations de copyright

Copyright © 2021 Korean Society for Sexual Medicine and Andrology.

Déclaration de conflit d'intérêts

The authors have nothing to disclose.

Références

Prostate Cancer Prostatic Dis. 2016 Dec;19(4):333-339
pubmed: 27595915
Andrology. 2014 Sep;2(5):741-7
pubmed: 25044637
J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24
pubmed: 17925537
J Sex Med. 2018 Sep;15(9):1260-1271
pubmed: 30145097
J Cancer Surviv. 2010 Jun;4(2):128-39
pubmed: 20091248
World J Urol. 2015 Sep;33(9):1281-9
pubmed: 25387877
Urology. 2018 Apr;114:155-162
pubmed: 29352986
Eur J Endocrinol. 2009 May;160(5):833-8
pubmed: 19208774
Andrology. 2020 Nov;8(6):1519-1529
pubmed: 31502758
J Endocrinol Invest. 2011 Mar;34(3):232-43
pubmed: 21297383
Medicine (Baltimore). 2017 Jul;96(27):e7368
pubmed: 28682886
Br J Pharmacol. 2017 Oct;174(20):3425-3442
pubmed: 27761903
Front Horm Res. 2018;49:131-155
pubmed: 29895018
JAMA. 2011 Dec 7;306(21):2359-66
pubmed: 22147380
J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):80-92
pubmed: 22406511
Hormones (Athens). 2017 Apr;16(2):115-123
pubmed: 28742500
J Clin Oncol. 2007 Jun 10;25(17):2420-5
pubmed: 17557956
Andrology. 2020 May;8(3):559-574
pubmed: 31743594
Expert Rev Clin Pharmacol. 2018 Apr;11(4):439-458
pubmed: 29505313
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Expert Opin Pharmacother. 2014 Sep;15(13):1903-26
pubmed: 25080279
Eur Urol. 2014 Apr;65(4):816-24
pubmed: 23453420
J Sex Med. 2020 Mar;17(3):447-460
pubmed: 31928918
Endocrinology. 2013 Sep;154(9):2992-3000
pubmed: 23782940
World J Mens Health. 2013 Aug;31(2):103-25
pubmed: 24044106
J Endocrinol Invest. 2020 Dec;43(12):1675-1687
pubmed: 32567016
J Clin Endocrinol Metab. 2010 Apr;95(4):1810-8
pubmed: 20173018
Eur Urol. 2015 Sep;68(3):386-96
pubmed: 25484142
J Clin Endocrinol Metab. 2015 Aug;100(8):3172-82
pubmed: 26000545
Geriatr Gerontol Int. 2016 Feb;16(2):155-66
pubmed: 26271226
Expert Rev Endocrinol Metab. 2019 Sep;14(5):321-334
pubmed: 31464531
J Sex Med. 2009 Dec;6(12):3274-88
pubmed: 19732305
Endocrinology. 2005 Aug;146(8):3506-17
pubmed: 15860558
Atherosclerosis. 1996 Aug 23;125(1):1-13
pubmed: 8831922
Andrology. 2020 Nov;8(6):1580-1589
pubmed: 32248652
PLoS One. 2015 Mar 20;10(3):e0117344
pubmed: 25794005
Minerva Endocrinol. 2016 Jun;41(2):196-210
pubmed: 26883937
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):451-460
pubmed: 29988099
BMC Cancer. 2016 Mar 03;16:180
pubmed: 26940836
J Diabetes Investig. 2016 Jul;7(4):629-36
pubmed: 27181717
J Urol. 2015 Jun;193(6):1963-9
pubmed: 25541340
Ann Oncol. 2013 May;24(5):1338-43
pubmed: 23277483
JAMA Neurol. 2017 Jan 1;74(1):75-81
pubmed: 27842176
BJU Int. 2014 Dec;114(6b):E82-E89
pubmed: 24612110
J Sex Med. 2011 Jul;8(7):2098-105
pubmed: 21561538
Mol Cell Endocrinol. 2014 Mar 25;384(1-2):143-54
pubmed: 24486698
J Sex Med. 2019 Jun;16(6):821-832
pubmed: 30962157
J Endocrinol. 2020 May;245(2):259-279
pubmed: 32134722
J Investig Med. 2017 Aug;65(6):964-973
pubmed: 28495861
J Endocrinol. 2006 Jun;189(3):595-604
pubmed: 16731790
Andrology. 2020 Sep;8(5):970-987
pubmed: 32026626
J Sex Med. 2018 Jun;15(6):820-838
pubmed: 29803351
World J Mens Health. 2017 Aug;35(2):65-76
pubmed: 28497912
J Thromb Haemost. 2014;12(3):297-305
pubmed: 24329981
Thromb Res. 2007;121(1):127-34
pubmed: 17451792
Circulation. 2010 Feb 16;121(6):833-40
pubmed: 20124128
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E519-E535
pubmed: 30645174
Thromb Res. 2018 Dec;172:94-103
pubmed: 30396049
J Clin Oncol. 2006 Sep 20;24(27):4448-56
pubmed: 16983113
Expert Opin Drug Saf. 2018 Mar;17(3):277-292
pubmed: 29334271
J Sex Med. 2012 Mar;9(3):887-902
pubmed: 22248394
PLoS One. 2014 Sep 29;9(9):e107516
pubmed: 25264674
J Immunol. 2001 Aug 15;167(4):2060-7
pubmed: 11489988

Auteurs

Giovanni Corona (G)

Endocrinology Unit, Medical Department, Azienda-Usl, Maggiore-Bellaria Hospital, Bologna, Italy. jocorona@libero.it.

Sandra Filippi (S)

Andrology, Female Endocrinology and Gender Incongruence Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Nicola Bianchi (N)

Endocrinology Unit, Medical Department, Azienda-Usl, Maggiore-Bellaria Hospital, Bologna, Italy.

Mauro Dicuio (M)

Urology Unit, Surgical Department, Azienda Usl, Maggiore-Bellaria Hospital, Bologna, Italy.
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden.

Giulia Rastrelli (G)

Andrology, Female Endocrinology and Gender Incongruence Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Sergio Concetti (S)

Urology Unit, Surgical Department, Azienda Usl, Maggiore-Bellaria Hospital, Bologna, Italy.

Alessandra Sforza (A)

Endocrinology Unit, Medical Department, Azienda-Usl, Maggiore-Bellaria Hospital, Bologna, Italy.

Mario Maggi (M)

Endocrinology Unit, Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy.

Classifications MeSH